The strategy implementation of immunotherapeutic for the treatment of cancer has gained prominence over the past decade. Oncolytic viruses (OVs) are viral strains that can infect and kill malignant cells without harming normal cells, while simultaneously stimulating the immune system and creating antitumor immunity.
https://www.creative-biolabs.com/oncolytic-virus/oncolytic-virotherapy-development-for-combination-therapy-with-cancer-immunotherapy.htm
2. Contents
Definition of Oncolytic Virus Immunotherapy
History of Oncolytic Virus Immunotherapy
Properties of Oncolytic Viruses
Mechanism of Action of Oncolytic Viruses
Clinical Trials of Oncolytic Virus Immunotherapy
Approved Oncolytic Virus Immunotherapy
Oncolytic Virus Combination Therapy
3. Oncolytic virus immunotherapy is a therapeutic approach to cancer
treatment that utilizes native or genetically modified viruses that
selectively replicate within tumor cells.
Definition of Oncolytic Virus Immunotherapy
5. Properties of Oncolytic Viruses
ss/ds DNA or RNA genome
ability to infect host cells and replicate
directly infect and lyse tumor cells in situ
do not require tumor-associated antigens in the vector
8. Mechanism of Action of Oncolytic Viruses
entry into cancer cells
exploit cancer immune evasion pathway
directly lytic effect on tumor cells
induce systemic anti-tumor immunity
target oncogenic pathways
16. Oncolytic Virus Combination Therapy
Combination with Adoptive T Cell Therapy
Combination with Immune Checkpoint Inhibitors
Combination with Cytokines
Combination with Cancer Vaccines
Combination with Chemoradiotherapy